FDA Drug/Biologics Approval BLA 761269 S-001, LECANEMAB-IRMB

FDA Drug/Biologics Approval BLA 761269 S-001, LECANEMAB-IRMB

Regular price $49.00 USD
Regular price Sale price $49.00 USD
Sale Sold out
BLA 761269 S-001
Company: EISAI INC
Drug Name: LEQEMBI
Active Ingredients: LECANEMAB-IRMB
Strength: 200MG/2ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 01/06/2023
Marketing Status: Prescription
Submission Classification: ORIG-1
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details